阿里巴巴(9988.HK)高开2.72% 二季度美股获桥水、高瓴、高盛等基金增持
格隆汇8月18日丨阿里巴巴(9988.HK)高开2.72%报249.4港元,盘前成交1.53亿港元,最新总市值53526亿港元。阿里巴巴(BABA.US)周一收涨1.18%报256.96美元,折算成港股市场价格为249.91港元/股。二季度持仓报告显示,桥水、高瓴、高盛等均在二季度明显增持了阿里巴巴美股。另外,此前有外媒称“美国要封杀阿里”,美国商务部长昨晚称,美国正忙于研究TikTok,尚未就阿里巴巴采取任何正式措施。这能有效缓解最近投资者对阿里可能被美国制裁的担忧。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.